Drugs / GD2-CAR-T cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06684639 | Dec 2024 → Dec 2029 expected | neuroblastoma | The General Hospital of Western Theater Command | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GD2-CAR-T cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06684639 ↗ |
| Modality | Cell therapy | “GD2-CAR-T cells” NCT06684639 ↗ |
| Route | Intravenous | “Split intravenous infusion of GD2-CAR-T cells” NCT06684639 ↗ |